Leslie, W. D. http://orcid.org/0000-0002-1056-1691
Schousboe, J. T.
Morin, S. N.
Martineau, P.
Lix, L. M.
Johansson, H.
McCloskey, E. V.
Harvey, N. C.
Kanis, J. A. http://orcid.org/0000-0002-3129-4326
Article History
Received: 26 September 2019
Accepted: 29 December 2019
First Online: 16 March 2020
Compliance with ethical standards
:
: Suzanne Morin: Nothing to declare for the context of this paper but has received research grants: Amgen and MerckEugene McCloskey: Nothing to declare for the context of this paper but numerous ad hoc consultancies/ speaking honoraria and/or research funding from Amgen, Bayer, General Electric, GSK, Hologic, Lilly, Merck Research Labs, Novartis, Novo Nordisk, Nycomed, Ono, Pfizer, ProStrakan, Roche, Sanofi-Aventis, Servier, Tethys, UBS, and Warner-ChilcottNicholas Harvey: Nothing to declare for the context of this paper, but has received consultancy/ lecture fees/ honoraria/ grant funding from Alliance for Better Bone Health, Amgen, MSD, Eli Lilly, Servier, Shire, UCB, Consilient Healthcare, Radius Health, Kyowa Kirin, and Internis PharmaJohn A. Kanis: Grants from Amgen, Lilly, Radius Health, and non-financial support from Medimaps outside the submitted workWilliam Leslie, Patrick Martineau, Lisa Lix, and Helena Johansson: No conflicts of interest